Search Result "Anacetrapib CETP"
Anacetrapib: A New Weapon Against Dyslipidemia
Journal: Current Clinical Pharmacology
Volume: 6 Issue: 4 Year: 2011 Page: 227-235
Author(s): Georgios Aperis, Christos Paliouras, Eirini Tsampikaki, Nikolaos Papakonstantinou, Polichronis Alivanis
Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 2 Year: 2012 Page: 102-110
Author(s): Raktim Kumar Ghosh, Samhati Mondal Ghosh
CETP Pharmacological Manipulation Transforming Human into Mouse: Is this Still a Viable Hypothesis?
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 12 Issue: 4 Year: 2012 Page: 266-278
Author(s): Enrique Morales-Villegas,Gualberto Moreno-Virgen,Philip J. Barter
The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3143-3149
Author(s): A.E. Bochem, J.A. Kuivenhoven, E.S.G. Stroes
Cholesteryl Ester Transfer Protein (CETP) Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2009 Page: 419-427
Author(s): Julianne A. Hunt, Zhijian Lu
CETP Inhibitory Activity of Chlorobenzyl Benzamides: QPLD Docking, Pharmacophore Mapping and Synthesis
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 1 Year: 2017 Page: 1391-1400
Author(s): Reema Abu Khalaf, Hamada Abd El-Aziz, Dima Sabbah, Ghadeer Albadawi, Ghassan Abu Sheikha
Cholesterol Ester Transfer Protein (CETP), Postprandial Lipemia and Hypolipidemic Drugs
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4345-4360
Author(s): G. D. Kolovou, K. K. Anagnostopoulou, P. M. Kostakou, D. P. Mikhailidis
Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 6 Year: 2012 Page: 720-724
Author(s): Thomas F. Luscher,Arnold von Eckardstein,Branko Simic
High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1480-1493
Author(s): Christian Besler, Kathrin Heinrich, Meliana Riwanto, Thomas F. Luscher, Ulf Landmesser
Type 2 Diabetes and HDL Dysfunction: A Key Contributor toGlycemic Control
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 3 Year: 2024 Page: 280-285
Author(s): Joan Carles Escolà -Gil